A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial

Srdan Verstovsek; Moshe Talpaz; Martha Wadleigh; Alessandro Isidori; Peter Te Boekhorst; Michael R. Savona; Prithviraj Bose; Olga Pozdnyakova; Ruben Mesa; Tarec C. El-Galaly; Jennifer O'Sullivan; Katia Gamel; Brian Higgins; Sudhakar Katakam; Boyan Todorov; Kerstin Trunzer; Claire N. Harrison

doi:10.3324/haematol.2023.284410

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial

Srdan Verstovsek, Moshe Talpaz, Martha Wadleigh, Alessandro Isidori, Peter Te Boekhorst, Michael R. Savona, Prithviraj Bose, Olga Pozdnyakova, Ruben Mesa, Tarec C. El-Galaly, Jennifer O'Sullivan, Katia Gamel, Brian Higgins, Sudhakar Katakam, Boyan Todorov, Kerstin Trunzer, Claire N. Harrison^*

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

1 Downloads (Pure)

Original language	English
Pages (from-to)	1977-1983
Number of pages	7
Journal	Haematologica
Volume	109
Issue number	6
DOIs	https://doi.org/10.3324/haematol.2023.284410
Publication status	Published - 1 Jun 2024

Access to Document

10.3324/haematol.2023.284410Licence: CC BY

11420-Article Text-83178-2-10-20240514Final published version, 4.83 MBLicence: CC BY

Cite this

Verstovsek, S., Talpaz, M., Wadleigh, M., Isidori, A., Te Boekhorst, P., Savona, M. R., Bose, P., Pozdnyakova, O., Mesa, R., El-Galaly, T. C., O'Sullivan, J., Gamel, K., Higgins, B., Katakam, S., Todorov, B., Trunzer, K., & Harrison, C. N. (2024). A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial. Haematologica, 109(6), 1977-1983. https://doi.org/10.3324/haematol.2023.284410

@article{538478c592ac4b418ab7857ba68ea28a,

title = "A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial",

author = "Srdan Verstovsek and Moshe Talpaz and Martha Wadleigh and Alessandro Isidori and {Te Boekhorst}, Peter and Savona, {Michael R.} and Prithviraj Bose and Olga Pozdnyakova and Ruben Mesa and El-Galaly, {Tarec C.} and Jennifer O'Sullivan and Katia Gamel and Brian Higgins and Sudhakar Katakam and Boyan Todorov and Kerstin Trunzer and Harrison, {Claire N.}",

year = "2024",

month = jun,

day = "1",

doi = "10.3324/haematol.2023.284410",

language = "English",

volume = "109",

pages = "1977--1983",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

Verstovsek, S, Talpaz, M, Wadleigh, M, Isidori, A, Te Boekhorst, P, Savona, MR, Bose, P, Pozdnyakova, O, Mesa, R, El-Galaly, TC, O'Sullivan, J, Gamel, K, Higgins, B, Katakam, S, Todorov, B, Trunzer, K & Harrison, CN 2024, 'A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial', Haematologica, vol. 109, no. 6, pp. 1977-1983. https://doi.org/10.3324/haematol.2023.284410

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial. / Verstovsek, Srdan; Talpaz, Moshe; Wadleigh, Martha et al.
In: Haematologica, Vol. 109, No. 6, 01.06.2024, p. 1977-1983.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib

T2 - stage 2 of a phase II trial

AU - Verstovsek, Srdan

AU - Talpaz, Moshe

AU - Wadleigh, Martha

AU - Isidori, Alessandro

AU - Te Boekhorst, Peter

AU - Savona, Michael R.

AU - Bose, Prithviraj

AU - Pozdnyakova, Olga

AU - Mesa, Ruben

AU - El-Galaly, Tarec C.

AU - O'Sullivan, Jennifer

AU - Gamel, Katia

AU - Higgins, Brian

AU - Katakam, Sudhakar

AU - Todorov, Boyan

AU - Trunzer, Kerstin

AU - Harrison, Claire N.

PY - 2024/6/1

Y1 - 2024/6/1

UR - http://www.scopus.com/inward/record.url?scp=85195228374&partnerID=8YFLogxK

U2 - 10.3324/haematol.2023.284410

DO - 10.3324/haematol.2023.284410

M3 - Comment/Letter to the editor

C2 - 38268448

AN - SCOPUS:85195228374

SN - 0390-6078

VL - 109

SP - 1977

EP - 1983

JO - Haematologica

JF - Haematologica

IS - 6

ER -

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial

Access to Document

Other files and links

Cite this